Profound Medical Corp. provided earnings guidance for full-year 2024. For the period, company expects total revenue to be in the range of $11.0 million to $12.0 million, which represents 53% to 67% growth compared to its prior year revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.97 CAD | +6.12% | +16.21% | +7.84% |
May. 15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 212M | |
+9.55% | 222B | |
+14.41% | 196B | |
+24.02% | 148B | |
+33.92% | 114B | |
+5.02% | 65.69B | |
+12.92% | 51.88B | |
+3.16% | 50.02B | |
-4.32% | 38.81B | |
-1.99% | 34.59B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Profound Medical Corp. Provides Earnings Guidance for Full-Year 2024